The Effect of Progesterone Levels on Pregnancy
Launched by SEZCAN MUMUSOGLU · Jan 12, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Ovarian stimulation with gonadotropins is a frequently used method in patients with unexplained infertility undergoing intrauterine insemination.
Pregnancy and live birth rates after ovarian stimulation; The number of follicles in ovulatory size and responsive to ovarian stimulation is affected by many factors such as the age of the woman and the duration of infertility. Progesterone production in the luteal phase is necessary to achieve successful treatment results by increasing the receptivity of the endometrium in the secretory phase.
In assisted reproductive techniques, exogenous prog...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients who have been decided for intrauterine insemination
- • Patients under the age of 40
- • Patients with a BMI of less than 40 kg / m2
- • Cycles triggered by rhCG
- • Those who have a signed and dated informed consent document that they have been informed about the study and that their consent has been obtained
- Exclusion Criteria:
- • Patients over the age of 40
- • Patients with BMI over 40 kg / m2
About Sezcan Mumusoglu
Sezcan Mumusoglu is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing and implementing cutting-edge therapeutic solutions, they collaborate with a diverse network of healthcare professionals, researchers, and institutions to ensure rigorous study design and ethical conduct. Their commitment to enhancing patient outcomes drives their meticulous approach to clinical trials, emphasizing safety, efficacy, and scientific integrity. Sezcan Mumusoglu's contributions are pivotal in bridging the gap between research and real-world applications, fostering the development of groundbreaking treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Gurkan Bozdag, Prof.
Study Chair
Hacettepe University
Galip Serdar Gunalp, Prof.
Study Chair
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials